Herpes type-2 virus antigens in human cervical carcinoma
Adelusi, B.; Osunkoya, B.O.; Fabiyi, A.
Obstetrics and Gynecology 47(5): 545-548
1976
ISSN/ISBN: 0029-7844 PMID: 772507 Document Number: 106070
Exfoliated cells from the cervices of 22 patients with histologically diagnosed squamous cell carcinoma of the cervix and from those of 24 control women were examined for herpes subtype 2 (HT-2) antigens by indirect immunofluorescence studies. This method demonstrated that cells from all the patients with carcinoma contained antigens related to HT-2 virus. In contrast, squamous cells from the cervices of 24 control women with no cervical disease and of 2 women with chronic cervicitis did not contain such HT-2 antigens. Although an etiologic role of HT-2 virus infection cannot yet be established, it is probable that such infection precedes neoplastic changes.
Document emailed within 1 workday
Related Documents
Heise, E.R.; Kucera, L.S.; Raben, M.; Homesley, H. 1979: Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients Cancer Research 39(10): 4022-4026Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Gilman, S.C.; Docherty, J.J.; Clarke, A.; Rawls, W.E. 1980: Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls Cancer Research 40(12): 4640-4647
Goodheart, C.R. 1974: Biochemical approaches to detection of herpes simplex virus type 2 in cervical carcinoma Cancer Research 34(5): 1136-1139
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
Kwaśniewska, A.; Korobowicz, E.; Zdunek, M.; Skoczyński, M.; Kwaśniewski, W.; Daniłoś, J.; Goździcka-Józefiak, A. 2009: Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples European Journal of Gynaecological Oncology 30(1): 65-70
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844
Schneweis, K.E.; Nahmias, A.J. 1971: Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 141(5): 471-487
Posevaia, T.A.; Barinskiĭ, I.F.; Grigor'ev, V.V.; Shuvaeva, N.I. 1982: Humoral immunity to herpes simplex virus type 2 in cervical cancer Voprosy Virusologii 27(3): 328-330
Colette Smit, C.P.,A.M.,J.T.,J.S.,B.B.,R.C.andN.H.T.M.D. 2007: Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and Hiv over time (19842003) European Journal of Epidemiology 22(12): 937-944
Horácek, J.; Rosol, M. 1973: The role of Herpes virus hominis 2 in the genesis of cervical carcinoma Zentralblatt für Gynakologie 95(36): 1278-1280
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88
Mmbaga, E.J.; Leyna, G.H.; Stray-Pedersen, B.; Klepp, K.-I. 2011: Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania East African Journal of Public Health 8(1): 28-32
Chen, M.H. 1985: Discovery of herpes simplex virus (HSV)-like particles in biopsy samples of cervical carcinoma Zhonghua Zhong Liu Za Zhi 7(6): 430-431
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610
Mahiane, S.G.; Ndong Nguema, E.P.; Pretorius, C.; Auvert, B. 2010: Mathematical models for coinfection by two sexually transmitted agents: the human immunodeficiency virus and herpes simplex virus type 2 case Applied Statistics 59(4): 547-572
Dada, A.J.; Ajayi, A.O.; Diamondstone, L.; Quinn, T.C.; Blattner, W.A.; Biggar, R.J. 1998: A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria Sexually Transmitted Diseases 25(5): 237-242
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264